Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-18 | 2021-04-29 | 135952 |
TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-25 | 2021-05-20 | 136286 |
TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Avoided shortage | 2021-05-20 | 2021-07-08 | 139722 |
TEVA-DILTIAZEM CD | 240MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-05-27 | 2021-07-09 | 140039 |
TEVA-DILTIAZEM CD | 240MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-06-03 | 2021-06-10 | 140372 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-15 | 2021-09-09 | 142610 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-22 | 2021-09-02 | 142908 |
TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-09-23 | 2021-10-14 | 146092 |
TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-17 | 2022-04-21 | 155134 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-24 | 2022-04-21 | 155563 |
TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-05-12 | 2022-07-01 | 160420 |
TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-08-18 | 2022-10-29 | 167226 |
TEVA-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-10-17 | 2023-07-28 | 172027 |
TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-01 | 2023-06-09 | 176818 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-02 | 2023-09-07 | 183419 |
TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-07-28 | 184219 |
TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-11-30 | 184222 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-06-27 | 190713 |
TEVA-AMPHETAMINE XR | 15MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-08-18 | 190755 |
TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-07-28 | 190758 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |